Search Results - "Sina, Asmaa"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    A MT1-MMP/NF-κB signaling axis as a checkpoint controller of COX-2 expression in CD133(+) U87 glioblastoma cells by Annabi, Borhane, Laflamme, Carl, Sina, Asmaa, Lachambre, Marie-Paule, Beliveau, Richard

    Published in Journal of neuroinflammation (09-03-2009)
    “…Abstract Background The CD133(+) stem cell population in recurrent gliomas is associated with clinical features such as therapy resistance, blood-brain barrier…”
    Get full text
    Journal Article
  2. 2

    Silencing of the MT1-MMP/ G6PT axis suppresses calcium mobilization by sphingosine-1-phosphate in glioblastoma cells by Fortier, Simon, Labelle, Dominique, Sina, Asmaa, Moreau, Robert, Annabi, Borhane

    Published in FEBS letters (05-03-2008)
    “…The contributions of membrane type-1 matrix metalloproteinase (MT1-MMP) and of the glucose-6-phosphate transporter (G6PT) in sphingosine-1-phosphate…”
    Get full text
    Journal Article
  3. 3

    MT1-MMP Down-regulates the Glucose 6-Phosphate Transporter Expression in Marrow Stromal Cells by Currie, Jean-Christophe, Fortier, Simon, Sina, Asmaa, Galipeau, Jacques, Cao, Jian, Annabi, Borhane

    Published in The Journal of biological chemistry (16-03-2007)
    “…Bone marrow-derived stromal cells (BMSC) are avidly recruited by experimental vascularizing tumors, which implies that they must respond to tumor-derived…”
    Get full text
    Journal Article
  4. 4

    Cell-based evidence for aminopeptidase N/CD13 inhibitor actinonin targeting of MT1-MMP-mediated proMMP-2 activation by Sina, Asmaa, Lord-Dufour, Simon, Annabi, Borhane

    Published in Cancer letters (08-07-2009)
    “…Abstract Recent profiling has identified the aminopeptidase N/CD13 inhibitor actinonin as a selective soluble secreted matrix metalloproteinase (MMP)…”
    Get full text
    Journal Article
  5. 5

    Abstract 4027: The lectin concanavalin-A induces cyclooxygenase-2 expression through an IKKgamma/NFkB-dependent pathway in U87 glioblastoma cells by Sina, Asmaa, Proulx-Bonneau, Sébastien, Annabi, Borhane

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Abstract The lectin from Canavalia ensiformis (Concanavalin-A, ConA), one of the most abundant lectins known, enables one to mimic biological…”
    Get full text
    Journal Article
  6. 6

    MT1-MMP Down-regulates the Glucose 6-Phosphate Transporter Expression in Marrow Stromal Cells: A MOLECULAR LINK BETWEEN PRO-MMP-2 ACTIVATION, CHEMOTAXIS, AND CELL SURVIVAL by Currie, Jean-Christophe, Fortier, Simon, Sina, Asmaa, Galipeau, Jacques, Cao, Jian, Annabi, Borhane

    Published in The Journal of biological chemistry (16-03-2007)
    “…Bone marrow-derived stromal cells (BMSC) are avidly recruited by experimental vascularizing tumors, which implies that they must respond to tumor-derived…”
    Get full text
    Journal Article
  7. 7

    The lectin concanavalin-A signals MT1-MMP catalytic independent induction of COX-2 through an IKKγ/NF-κB-dependent pathway by Sina, Asmaa, Proulx-Bonneau, Sébastien, Roy, Alain, Poliquin, Laurent, Cao, Jian, Annabi, Borhane

    “…The lectin from Canavalia ensiformis (Concanavalin-A, ConA), one of the most abundant lectins known, enables one to mimic biological lectin/carbohydrate…”
    Get full text
    Journal Article
  8. 8

    The lectin concanavalin-A signals MT1-MMP catalytic independent induction of COX-2 through an IKKgamma/NF-kappaB-dependent pathway by Sina, Asmaa, Proulx-Bonneau, Sébastien, Roy, Alain, Poliquin, Laurent, Cao, Jian, Annabi, Borhane

    “…The lectin from Canavalia ensiformis (Concanavalin-A, ConA), one of the most abundant lectins known, enables one to mimic biological lectin/carbohydrate…”
    Get full text
    Journal Article
  9. 9

    A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells by Annabi, Borhane, Laflamme, Carl, Sina, Asmaa, Lachambre, Marie-Paule, Béliveau, Richard

    Published in Journal of neuroinflammation (09-03-2009)
    “…The CD133(+) stem cell population in recurrent gliomas is associated with clinical features such as therapy resistance, blood-brain barrier disruption and,…”
    Get full text
    Journal Article